<SEC-DOCUMENT>0001213900-20-032945.txt : 20201023
<SEC-HEADER>0001213900-20-032945.hdr.sgml : 20201023
<ACCEPTANCE-DATETIME>20201023091733
ACCESSION NUMBER:		0001213900-20-032945
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20201023
DATE AS OF CHANGE:		20201023

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KBL MERGER CORP. IV
		CENTRAL INDEX KEY:			0001690080
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		IRS NUMBER:				813832378
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-234650
		FILM NUMBER:		201256141

	BUSINESS ADDRESS:	
		STREET 1:		150 WEST 56TH STREET SUITE 5901
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		212-319-5555

	MAIL ADDRESS:	
		STREET 1:		150 WEST 56TH STREET SUITE 5901
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ea128812-424b3_kblmerger.htm
<DESCRIPTION>PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Filed pursuant to Rule 424(b)(3)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-234650</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20pt 0pt 0"><B>SUPPLEMENT NO. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20pt 0pt 0"><B>(to proxy statement / prospectus</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20pt 0pt 0"><B>dated October 9, 2020)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 20pt 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>KBL MERGER CORP. IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This Supplement No.
1 to the proxy statement / prospectus of KBL Merger Corp. IV (&ldquo;KBL&rdquo;) dated October 9, 2020 (the &ldquo;Original Prospectus&rdquo;)
is being filed solely for the purpose of supplementing and updating the information contained in the Original Prospectus, relating
to the special meeting of the stockholders of KBL described therein (the &ldquo;special meeting&rdquo;), to change the date of
the special meeting from October 26, 2020 to November 5, 2020.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As a result of this
change, the special meeting will now be held at 10:00 a.m., local time, on Thursday, November 5, 2020, at the offices of KBL located
at 30 Park Place, Suite 64B, New York, NY 10007.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Also as a result of
the change of the date for the special meeting, the date and time by which stockholders seeking to exercise redemption rights must
tender their public shares physically or electronically and submit a request in writing that we redeem their public shares for
cash to our transfer agent, Continental Stock Transfer &amp; Trust Company, is being extended to 5:00 p.m., Eastern Time, on November
3, 2020 (two business days before the special meeting).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have
determined to postpone the special meeting so that it better aligns with the anticipated timing of the closing of the
proposed business combination as contemplated by the Business Combination Agreement, dated as of July 25, 2019, by and among
KBL, KBL Merger Sub, Inc., 180 Life Sciences Corp., Katexco Pharmaceuticals Corp., CannBioRex Pharmaceuticals Corp., 180
Therapeutics L.P., and Lawrence Pemble, in his capacity as stockholder representative (the &ldquo;Business Combination
Agreement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Other than as set forth
in this supplement, the information contained in the Original Prospectus, including the proposals described therein, remain unchanged.
On or about October 12, 2020, we mailed the Original Prospectus to holders of record of our common stock as of the close of business
on September 30, 2020. This supplement should be read in conjunction with the Original Prospectus, which contains important information
about KBL, the special meeting and the proposals on which our stockholders are being asked to vote at the special meeting, including,
without limitation, those proposals relating to the proposed business combination contemplated by the Business Combination Agreement.
If there is any inconsistency between the information in the Original Prospectus, and this supplement, you should rely on the information
in this supplement. We urge you to read the Original Prospectus carefully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We will continue to
solicit proxies from stockholders during the period prior to the special meeting. Only the holders of our common stock as of the
close of business on September 30, 2020, the record date for the special meeting, are entitled to vote at the special meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>The date of this supplement is October
23, 2020</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
